CMV seronegative blood components
The CMV Seronegative Blood Components for Clinical Use - Clinical Guidance (PDF 462KB) policy sets out the patient groups for whom transfusion with Cytomegalovirus (CMV) seronegative blood components / products is clinically indicated and supported by evidence, where available. It also establishes criteria for holding of CMV seronegative blood components across SA Health based on the SA Health Clinical Services Capability Framework.
See the Guidance Summary (PDF 113KB) for a a one page summary of the policy.
For more information, please contact Blood, Organ and Tissue Programs.